2 Small-Cap Stocks Set to Shine in a Bull Market

Core Insights - Small-cap stocks are experiencing significant gains in bullish markets due to their growth-oriented profiles and sensitivity to improving economic conditions [1][2] - The iShares Russell 2000 ETF has increased over 13% this quarter, indicating strong investor interest in small-cap opportunities [2] Company Summaries CureVac - CureVac, a biopharmaceutical company, has a strong pipeline including mRNA-based vaccines and therapies, with a recent revenue increase of 3000% year-over-year to $520 million, largely due to a$423.5 million payment from GSK [3][4] - The company has a current P/E ratio of 5.75 and a price target of $10, suggesting a potential upside of over 200$583.4 million in cash, extending its runway beyond 2028 [4] HeartCore Enterprises - HeartCore Enterprises, a Japan-based software company, has shifted towards recurring revenue through multi-year licensing agreements, enhancing its customer experience offerings [7] - The company has seen a stock increase of 150% year-to-date, with Q3 results showing an EPS of $0.53, exceeding estimates by over 50% [8][9] - HeartCore has a client retention rate of 25.9% over ten years and projects a 12% sales increase from CMS customers in FY 2025, although it remains under the radar with low institutional ownership [9]